1. Home
  2. Browse
  3. HRA001818
HRA001818
   HRA001818.xlsx
Title:
epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
Release date:
2022-01-13
Description:
We retrospectively reviewed the prognostic significance of 53 people with EGFRm NSCLC diagnosed with LM. Survival was improved in people with EGFRm NSCLC diagnosed with LM who received high-level EGFR TKIs regardless of gene mutation status in tissue and cerebrospinal fluid (CSF). Those with LM with peripheral pulmonary lesions, partial response or stable disease, and mutated EGFR was eliminated in blood, are likely to benefit from this treatment.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA007897
Study type:
Disease Study
Disease name:
non-small cell lung carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC001067
DAC name:
DNA-seq
Contact person:
cong minghua
Email:
congmh@cicams.ac.cn
Description:
We retrospectively reviewed the prognostic significance of 53 people with EGFRm NSCLC diagnosed with LM by NGS.
Individuals & samples
Files
Request Data
Submitter:   cong minghua / congmh@cicams.ac.cn
Organization:   National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Submission date:   2022-01-11
Requests:   -